scispace - formally typeset
Search or ask a question
Author

Richard G. Weleber

Bio: Richard G. Weleber is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Retinitis pigmentosa & Visual acuity. The author has an hindex of 65, co-authored 250 publications receiving 14382 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: In dogs, RPE65 gene therapy with the same vector at lower doses improved vision-guided behavior, but only higher doses resulted in improvements in retinal function that were detectable with the use of ERG, and comparison with the results obtained in the dog model indicates that there is a species difference in the amount of R PE65 required to drive the visual cycle.
Abstract: BackgroundMutations in RPE65 cause Leber’s congenital amaurosis, a progressive retinal degenerative disease that severely impairs sight in children. Gene therapy can result in modest improvements in night vision, but knowledge of its efficacy in humans is limited. MethodsWe performed a phase 1–2 open-label trial involving 12 participants to evaluate the safety and efficacy of gene therapy with a recombinant adeno-associated virus 2/2 (rAAV2/2) vector carrying the RPE65 complementary DNA, and measured visual function over the course of 3 years. Four participants were administered a lower dose of the vector, and 8 were administered a higher dose. In a parallel study in dogs, we investigated the relationship among vector dose, visual function, and electroretinography (ERG) findings. ResultsImprovements in retinal sensitivity were evident, to varying extents, in six participants for up to 3 years, peaking at 6 to 12 months after treatment and then declining. No associated improvement in retinal function was d...

599 citations

Journal ArticleDOI
John G. Clarkson1, Elaine Chuang1, Donald Gass1, Maria Pedroso1, Tony Cubillas1, Erlinda S. Duria1, Ditte J. Hess1, Isabel Rams1, Marguerite Ball1, Alex Gutierrez1, Nayla Muniz1, June Thompson1, Michele Pall1, Charles J. Pappas1, Daniel Finkelstein2, Arnall Patz2, Dolores Rytel2, Judy Belt2, Dennis Cain2, Terri Cain2, David Emmert2, Terry George2, Mark Herring2, Pete Sotirakos2, David H. Orth, Timothy P. Flood, Kirk H. Packo, Toni Larsen, Nancy Perez, D. A. Bryant, Don Doherty, Jay Fitzgerald, Martha Gordon, Cynthia Holod, Kathy Kwiatkowski, Celeste MacLeod, Chris Morrison, Charlotte Westcott, Michael L. Klein3, David J. Wilson3, Richard G. Weleber3, Susan K. Nolte3, Nancy Hurlburt3, Mark Evans3, Patrick Wallace3, Peter N. Steinkamp3, Debora Funkner3, Cathy Gordon3, Clement L. Trempe, Alex E. Jalkh, John J. Weiter, Sherry Anderson, Dennis Donovan, Tom O'Day, Gerald R. Friedman, Rodney L. Immerman, Gabriel Coscas, Gisèle Soubrane, Rose Marie Haran, Christophe Debibie, Jean Gizelsky, Ingolf H. L. Wallow4, Guillermo de Venecia4, George Bresnick4, Sandra Larson4, Sandy Fuller4, Bob Harrison4, Gene Knutson4, Michael W. Neider4, Greg Weber4, Ruth Bahr4, Bonnie Grosnick4, Robert Lazorik4, Helen Lyngaas4, Diane Quackenboss4, Guy Somers4, Froncie A. Gutman5, Sanford Myers5, Tina Kiss5, Deborah Ross5, Pamela Vargo5, Janet Edgarton5, Sue Hanson5, Janet Nader5, Nancy Tomsak5, Lawrence J. Singerman, Hernando Zegarra, Susan Lichterman, Adrienne Fowler Kramer, Sheila Smith-Brewer, Pam Brown Rowe, Geraldine Daley, Anne Pinter, Kathy Coreno, Lori Cooper, Marty Delisio, Donna Cross, Wendy Lord, Argye Hillis6, Mark W. Riggs6, Cheryl Kasberg-Preece6, M. Hasan Rajab6, Krista Carlson Giniewicz6, Kevin Gilmore6, Carol Zimmerman6, Mary Lou Lewis7, Maria Cristina Wells7, Julie Lord Forbes7, Kathleen C. Fetzer7, Heather McNish7, George H. Bresnick4, Lissa McNulty4, Jim Baliker4, Linda Alanen4, Laura Gentry4, Richard L. Mowery8, Donald F. Everett8, Robert J. Hardy, Gary W. Abrams, Robert N. Frank, Maureen G. Maguire, Abner V. McCall 
TL;DR: In this article, the efficacy of macular grid photocoagulation in preserving or improving central visual acuity in eyes with macular edema due to central vein occlusion was evaluated.

505 citations

Journal ArticleDOI
TL;DR: The results suggest that NR2E3 has a role in determining photoreceptor phenotype during human retinogenesis, and may be due to abnormal cone cell fate determination during retinal development.
Abstract: Hereditary human retinal degenerative diseases usually affect the mature photoreceptor topography by reducing the number of cells through apoptosis, resulting in loss of visual function1. Only one inherited retinal disease, the enhanced S-cone syndrome (ESCS), manifests a gain in function of photoreceptors. ESCS is an autosomal recessive retinopathy in which patients have an increased sensitivity to blue light; perception of blue light is mediated by what is normally the least populous cone photoreceptor subtype, the S (short wavelength, blue) cones2,3,4,5,6,7,8. People with ESCS also suffer visual loss, with night blindness occurring from early in life, varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration. The altered ratio of S- to L/M-cone photoreceptor sensitivity in ESCS may be due to abnormal cone cell fate determination during retinal development7. In 94% of a cohort of ESCS probands we found mutations in NR2E3 (also known as PNR), which encodes a retinal nuclear receptor recently discovered to be a ligand-dependent transcription factor9. Expression of NR2E3 was limited to the outer nuclear layer of the human retina. Our results suggest that NR2E3 has a role in determining photoreceptor phenotype during human retinogenesis.

461 citations

Journal ArticleDOI
TL;DR: By sequencing the coding regions of CRYAA, it is found that a missense mutation, R116C, is associated with ADCC in this family of congenital cataracts, and an ADCC gene in family ADCC-2 is mapped to chromosome 21q22.3 near the alpha-crystallin geneCRYAA.
Abstract: Congenital cataracts are a common major abnormality of the eye that frequently cause blindness in infants. At least a third of all cases are familial; autosomal dominant congenital cataract (ADCC) appears to be the most common familial form in the Western world. We have mapped an ADCC gene in family ADCC-2 to chromosome 21q22.3 near the alpha-crystallin gene CRYAA. By sequencing the coding regions of CRYAA, we found that a missense mutation, R116C, is associated with ADCC in this family.

448 citations

Journal ArticleDOI
TL;DR: The identification of the gene BBS1 is reported and show that a missense mutation of this gene is a frequent cause of BBS, and data is provided showing that this common mutation is not involved in triallelic inheritance.
Abstract: Bardet-Biedl syndrome (BBS, OMIM 209900) is a genetic disorder with the primary features of obesity, pigmentary retinopathy, polydactyly, renal malformations, mental retardation and hypogenitalism. Individuals with BBS are also at increased risk for diabetes mellitus, hypertension and congenital heart disease. What was once thought to be a homogeneous autosomal recessive disorder is now known to map to at least six loci: 11q13 (BBS1), 16q21 (BBS2), 3p13 p12 (BBS3), 15q22.3 q23 (BBS4), 2q31 (BBS5) and 20p12 (BBS6). There has been considerable interest in identifying the genes that underlie BBS, because some components of the phenotype are common. Cases of BBS mapping ro BBS6 are caused by mutations in MKKS; mutations in this gene also cause McKusick-Kaufman syndrome (hydrometrocolpos, post-axial polydactyly and congenital heart defects). In addition, we recently used positional cloning to identify the genes underlying BBS2 (ref. 16) and BBS4 (ref. 17). The BBS6 protein has similarity to a Thermoplasma acidophilum chaperonin, whereas BBS2 and BBS4 have no significant similarity to chaperonins. It has recently been suggested that three mutated alleles (two at one locus, and a third at a second locus) may be required for manifestation of BBS (triallelic inheritance). Here we report the identification of the gene BBS1 and show that a missense mutation of this gene is a frequent cause of BBS. In addition, we provide data showing that this common mutation is not involved in triallelic inheritance.

350 citations


Cited by
More filters
Journal ArticleDOI

[...]

08 Dec 2001-BMJ
TL;DR: There is, I think, something ethereal about i —the square root of minus one, which seems an odd beast at that time—an intruder hovering on the edge of reality.
Abstract: There is, I think, something ethereal about i —the square root of minus one. I remember first hearing about it at school. It seemed an odd beast at that time—an intruder hovering on the edge of reality. Usually familiarity dulls this sense of the bizarre, but in the case of i it was the reverse: over the years the sense of its surreal nature intensified. It seemed that it was impossible to write mathematics that described the real world in …

33,785 citations

Journal ArticleDOI
06 Jun 1986-JAMA
TL;DR: The editors have done a masterful job of weaving together the biologic, the behavioral, and the clinical sciences into a single tapestry in which everyone from the molecular biologist to the practicing psychiatrist can find and appreciate his or her own research.
Abstract: I have developed "tennis elbow" from lugging this book around the past four weeks, but it is worth the pain, the effort, and the aspirin. It is also worth the (relatively speaking) bargain price. Including appendixes, this book contains 894 pages of text. The entire panorama of the neural sciences is surveyed and examined, and it is comprehensive in its scope, from genomes to social behaviors. The editors explicitly state that the book is designed as "an introductory text for students of biology, behavior, and medicine," but it is hard to imagine any audience, interested in any fragment of neuroscience at any level of sophistication, that would not enjoy this book. The editors have done a masterful job of weaving together the biologic, the behavioral, and the clinical sciences into a single tapestry in which everyone from the molecular biologist to the practicing psychiatrist can find and appreciate his or

7,563 citations

Journal ArticleDOI
15 Apr 2005-Science
TL;DR: A genome-wide screen for polymorphisms associated with age-related macular degeneration revealed a polymorphism in linkage disequilibrium with the risk allele representing a tyrosine-histidine change at amino acid 402 in the complement factor H gene.
Abstract: Age-related macular degeneration (AMD) is a major cause of blindness in the elderly. We report a genome-wide screen of 96 cases and 50 controls for polymorphisms associated with AMD. Among 116,204 single-nucleotide polymorphisms genotyped, an intronic and common variant in the complement factor H gene ( CFH ) is strongly associated with AMD (nominal P value -7 ). In individuals homozygous for the risk allele, the likelihood of AMD is increased by a factor of 7.4 (95% confidence interval 2.9 to 19). Resequencing revealed a polymorphism in linkage disequilibrium with the risk allele representing a tyrosine-histidine change at amino acid 402. This polymorphism is in a region of CFH that binds heparin and C-reactive protein. The CFH gene is located on chromosome 1 in a region repeatedly linked to AMD in family-based studies.

4,459 citations

Journal ArticleDOI
15 Apr 2005-Science
TL;DR: DNA resequencing of the complement factor H gene within this haplotype revealed a common coding variant that significantly increases the risk for AMD with odds ratios between 2.45 and 5.57, which likely explains ∼43% of AMD in older adults.
Abstract: Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in the elderly whose etiology remains largely unknown. Previous studies identified chromosome 1q32 as harboring a susceptibility locus for AMD. We used single-nucleotide polymorphisms to interrogate this region and identified a strongly associated haplotype in two independent data sets. DNA resequencing of the complement factor H gene within this haplotype revealed a common coding variant, Y402H, that significantly increases the risk for AMD with odds ratios between 2.45 and 5.57. This common variant likely explains approximately 43% of AMD in older adults.

2,463 citations

Journal ArticleDOI
TL;DR: This review summarizes the current knowledge of RPE functions and describes how failure of these functions causes loss of visual function.
Abstract: Located between vessels of the choriocapillaris and light-sensitive outer segments of the photoreceptors, the retinal pigment epithelium (RPE) closely interacts with photoreceptors in the maintenance of visual function. Increasing knowledge of the multiple functions performed by the RPE improved the understanding of many diseases leading to blindness. This review summarizes the current knowledge of RPE functions and describes how failure of these functions causes loss of visual function. Mutations in genes that are expressed in the RPE can lead to photoreceptor degeneration. On the other hand, mutations in genes expressed in photoreceptors can lead to degenerations of the RPE. Thus both tissues can be regarded as a functional unit where both interacting partners depend on each other.

2,387 citations